Rheumatoid Arthritis

ALN

Risk of Serious Infection, Glucocorticoid Use Are Linked Among Patients With RA

While low-dose glucocorticoids are commonly used in the management of rheumatoid arthritis, the safety of the medications’ long-term use is unclear. Researchers evaluated the association between long-term low-dose glucocorticoid use and risk of hospitalized infection among patients with RA receiving stable DMARD therapy.

Rheumatology Consultant

Pop Quiz: Treat-to-Target Recommendations for RA

The American College of Rheumatology’s guideline for the treatment of rheumatoid arthritis includes recommendations on when to implement a treat-to-target strategy. Test your knowledge of these recommendations in our latest pop quiz!

ALN

Who Is Most Likely to Experience Adverse Noninflammatory Symptoms During RA Remission?

Low back pain, degenerative knee pain, and widespread body pain due to fibromyalgia were some of the adverse noninflammatory symptoms that patients in remission from rheumatoid arthritis reported having experienced. Researchers assessed the relationship between these symptoms and disease characteristics.

Rheumatology Consultant

A Potential Key in RA Treatment Personalization: The Presence of CAD

Researchers sought to determine the ways in which rheumatoid arthritis impacts the risk of myocardial infarction, major adverse cardiovascular events, and all-cause mortality among patients with and without coronary artery disease.

ALN

Biological DMARDs May Reduce Lymphoma Risk Among Patients With RA

The researchers sought to determine the association between biological disease-modifying antirheumatic drugs and the risk of malignant lymphomas among patients with rheumatoid arthritis.